Services: Diversified Services

Genetic Technologies Limited (GENE: NASDAQ)

$1.38 0.04 | 2.99%
04/17/14 - 01:30 PM ET
Company Income Statement
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Sales 7.78M 11.60M 19.53M 8.29M
Cost of Sales 1.44M 1.42M 1.52M 2.31M
Gross Operating Profit 6.34M 10.18M 18.02M 5.98M
Selling, General, and Administrative Expenses 11.21M 11.53M 11.56M 9.60M
Research & Development 3.21M 4.13M 4.68M 76.49K
Operating Income before D & A (EBITDA) -8.08M -5.47M 1.78M -3.69M
Depreciation & Amortization 369.59K 575.48K 659.29K 3.15M
Interest Income 0.00 624.50K 0.00 0.00
Other Income - Net 218.51K 46.75K -68.62K 496.46K
Special Income / Charges 0.00 0.00 0.00 -1.52M
Total Income Before Interest Expenses (EBIT) -8.64M -5.38M 1.05M -7.87M
Interest Expense 36.16K 46.31K 87.57K 85.34K
Pre-Tax Income -8.68M -5.42M 963.32K -7.95M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest -47.43K -9.53K -9.26K -9.72K
Net Income From Continuing Operations -8.68M -5.42M 963.32K -7.95M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -8.68M -5.42M 963.32K -7.95M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -8.63M -5.41M 972.58K -7.94M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-8.68M -5.42M 963.32K -6.43M
Preferred Dividends
Net Income Available To Common -8.68M -5.42M 963.32K -7.95M
Basic EPS from Continuing Ops. -0.55 -0.35 0.07 -0.63
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.55 -0.35 0.07 -0.63
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 -0.01
Basic EPS, Total -0.55 -0.35 0.07 -0.64
Basic Normalized Net Income/Share -0.55 -0.35 0.07 -0.51
EPS fr Continuing Ops. -0.55 -0.35 0.07 -0.63
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.55 -0.35 0.07 -0.63
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 -0.01
EPS, Total -0.55 -0.35 0.07 -0.64
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.55 -0.35 0.07 -0.51
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with GENE

Latest GENE Headlines from TheStreet

More Financial News for GENE

Press Releases for GENE

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter